Improving Informed Decision Making for Cancer Clinical Trial Participation
Overview
- Phase
- N/A
- Intervention
- Clinical Trial Educational Video
- Conditions
- Educational Problems
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Enrollment
- 581
- Locations
- 1
- Primary Endpoint
- Proportion of patients who show intention to participate or to consider CTs as an appropriate treatment option for cancer.
- Status
- Active, Not Recruiting
- Last Updated
- last month
Overview
Brief Summary
The goal of this study is to develop and pilot test a multi-communication approach to improve informed decision-making about cancer Clinical Trials (CTs) participation by increasing awareness of CTs and Mays Cancer Center (MCC) services (treatment care capacities, reputation and resources), positive attitudes towards CTs, self-efficacy and intentions to consider CTs as an appropriate treatment option for cancer (intention to participate) among patients attending the MCC (clinic-based setting) and the general public in selected Bexar County areas (community-based settings).
Detailed Description
The proposed two-year study involves a randomized controlled educational trial featuring a 2-group parallel cohort design with random assignment of 400 cancer patients from the MCC to the intervention or usual care control group. Intervention participants will receive 3 components: 1) a bilingual culturally relevant educational video, 2) a low-literacy booklet and 3) support from a patient navigator to empower new cancer patients to make informed decisions about cancer CT participation by increasing awareness of clinical trials and MCC services, positive attitudes and intentions to consider CTs as an appropriate treatment option for cancer. The usual care control group will receive a general CT fact sheet. The community setting will involve a community awareness campaign including 400 community members, with 3 components: 1) an educational session delivered via PowerPoint presentation or flip chart, 2) a low-literacy booklet, and 3) support from a community health educator to raise awareness, positive attitudes and intentions to consider CTs as an appropriate treatment option for cancer and promote the MCC services among community members in Bexar County.
Investigators
Patricia Chalela
Associate Professor
The University of Texas Health Science Center at San Antonio
Eligibility Criteria
Inclusion Criteria
- •Newly diagnosed cancer patients (within 1 year) attending any of the clinics at the MCC
- •Patients who have not participated in a Clinical Trial before
- •English or Spanish-speaking
- •Able to provide informed consent
Exclusion Criteria
- •Younger than 18 years
- •Patients who have already had a consultation with their doctor to discuss treatment options
- •Patients who have participated in a Clinical Trial before
- •Unable to provide informed consent
Arms & Interventions
Intervention Group
Participants in the intervention group will receive 3 components: 1) a bilingual, culturally tailored clinical trial educational video, 2) a low literacy booklet, and 3) support from a patient navigator to empower cancer patients to make informed decisions about cancer clinical trial participation by increasing awareness of clinical trials and MCC services, positive attitudes and intentions to consider clinical trials as an appropriate treatment option for cancer.
Intervention: Clinical Trial Educational Video
Intervention Group
Participants in the intervention group will receive 3 components: 1) a bilingual, culturally tailored clinical trial educational video, 2) a low literacy booklet, and 3) support from a patient navigator to empower cancer patients to make informed decisions about cancer clinical trial participation by increasing awareness of clinical trials and MCC services, positive attitudes and intentions to consider clinical trials as an appropriate treatment option for cancer.
Intervention: Low literacy booklet
Intervention Group
Participants in the intervention group will receive 3 components: 1) a bilingual, culturally tailored clinical trial educational video, 2) a low literacy booklet, and 3) support from a patient navigator to empower cancer patients to make informed decisions about cancer clinical trial participation by increasing awareness of clinical trials and MCC services, positive attitudes and intentions to consider clinical trials as an appropriate treatment option for cancer.
Intervention: Navigator
Usual Care Control Group
Participants in the usual care control group will receive a general clinical trial fact sheet.
Intervention: Clinical Trial Fact Sheet
Outcomes
Primary Outcomes
Proportion of patients who show intention to participate or to consider CTs as an appropriate treatment option for cancer.
Time Frame: Up to 3 months after the index oncology visit
The percentage of patients who increased intentions to participate in a CT after the intervention compared with baseline.
Secondary Outcomes
- Proportion of patients who show increase in knowledge/awareness regarding CT participation.(Up to 3 months after the index oncology visit)
- Proportion of patients who show improved attitudes regarding CT participation.(Up to 3 months after the index oncology visit)
- Proportion of patients eligible for designated clinical trials who actually enroll in one of these trials.(Up to 3 months after the index oncology visit)